$388 Million is the total value of SECTOR GAMMA AS's 31 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 21.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $54,479,000 | +4.5% | 883,106 | +4.7% | 14.04% | +20.4% |
| BIIB | Buy | BIOGEN INC | $29,431,000 | +56.0% | 110,230 | +19.2% | 7.58% | +79.7% |
| INCY | Sell | INCYTE CORP | $27,908,000 | -20.0% | 418,794 | -8.8% | 7.19% | -7.9% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $25,139,000 | +4.7% | 353,627 | +13.5% | 6.48% | +20.7% |
| CAH | Sell | CARDINAL HEALTH INC | $23,918,000 | +18.5% | 358,700 | -7.1% | 6.16% | +36.6% |
| MRK | Sell | MERCK & CO INC | $21,802,000 | -42.3% | 253,159 | -38.9% | 5.62% | -33.5% |
| MDT | Sell | MEDTRONIC PLC | $21,799,000 | -16.4% | 269,957 | -7.1% | 5.62% | -3.7% |
| ANTM | Buy | ELEVANCE HEALTH INC | $20,910,000 | +26.3% | 46,032 | +34.2% | 5.39% | +45.5% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $17,364,000 | +21.8% | 166,080 | +22.3% | 4.48% | +40.2% |
| CNC | Buy | CENTENE CORP DEL | $15,683,000 | +2.0% | 201,555 | +10.9% | 4.04% | +17.4% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $14,996,000 | -24.5% | 387,184 | -27.3% | 3.86% | -13.0% |
| CI | Sell | CIGNA CORP NEW | $14,017,000 | -19.8% | 50,517 | -23.8% | 3.61% | -7.6% |
| BRKR | Sell | BRUKER CORP | $12,626,000 | -19.9% | 237,958 | -5.2% | 3.25% | -7.7% |
| SGEN | Buy | SEAGEN INC | $11,594,000 | +29.0% | 84,730 | +66.8% | 2.99% | +48.6% |
| NUVA | Buy | NUVASIVE INC | $10,893,000 | -10.5% | 248,649 | +0.5% | 2.81% | +3.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $9,291,000 | +6.5% | 109,604 | +4.1% | 2.39% | +22.6% |
| BAX | New | BAXTER INTL INC | $9,104,000 | – | 169,028 | +100.0% | 2.35% | – |
| QGEN | Buy | QIAGEN NV | $8,424,000 | -11.5% | 204,074 | +1.2% | 2.17% | +1.9% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $7,264,000 | +18.6% | 164,223 | -0.7% | 1.87% | +36.6% |
| BIO | Buy | BIO RAD LABS INCcl a | $5,001,000 | -14.3% | 11,988 | +1.7% | 1.29% | -1.2% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $4,531,000 | +18.4% | 115,696 | -2.3% | 1.17% | +36.4% |
| PTCT | Buy | PTC THERAPEUTICS INC | $4,352,000 | +28.0% | 86,692 | +2.2% | 1.12% | +47.4% |
| CVS | Sell | CVS HEALTH CORP | $4,143,000 | -73.4% | 43,443 | -74.2% | 1.07% | -69.4% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $3,193,000 | -30.8% | 68,612 | -15.1% | 0.82% | -20.3% |
| UHS | UNIVERSAL HLTH SVCS INCcl b | $2,388,000 | -12.4% | 27,077 | 0.0% | 0.62% | +0.8% | |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $1,885,000 | -31.7% | 45,520 | -1.5% | 0.49% | -21.2% |
| VIR | Sell | VIR BIOTECHNOLOGY INC | $1,731,000 | -38.3% | 89,808 | -18.5% | 0.45% | -29.0% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,589,000 | -4.1% | 1,346,904 | -8.2% | 0.41% | +10.5% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $1,385,000 | -77.8% | 6,921 | -83.8% | 0.36% | -74.5% |
| NVAX | Buy | NOVAVAX INC | $1,033,000 | -63.7% | 56,735 | +2.6% | 0.27% | -58.2% |
| EMBECTA CORP | $151,000 | +13.5% | 5,246 | 0.0% | 0.04% | +30.0% | ||
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -123,713 | -100.0% | -0.22% | – |
| Exit | SOMALOGIC INC | $0 | – | -301,224 | -100.0% | -0.30% | – | |
| QTRX | Exit | QUANTERIX CORP | $0 | – | -88,670 | -100.0% | -0.32% | – |
| PFE | Exit | PFIZER INC | $0 | – | -100,000 | -100.0% | -1.17% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -49,205 | -100.0% | -1.20% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -33,474 | -100.0% | -2.11% | – |
| OGN | Exit | ORGANON & CO | $0 | – | -356,089 | -100.0% | -2.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.